CMVpp65-specific T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CMVpp65-specific T cells, covering 2020-12-16 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]